{
    "other_tests": [
        {
            "procedure_name": "Biopsy",
            "date": "Not specified",
            "findings": "Gleason 8 prostate adenocarcinoma in 6 out of 6 cores (80% involvement). Immunohistochemistry showed abundant androgen receptor expression in all cancer cells, but no estrogen or progesterone receptor expression.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Transrectal ultrasound-guided biopsy",
            "date": "Not specified",
            "findings": "Gleason 8 prostate adenocarcinoma in 6 out of 6 cores (80% involvement).",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Antiandrogen treatment",
            "date": "Not specified",
            "findings": "PSA level decreased by 68% to 77 ng/mL after 6 weeks.",
            "changes_over_time": "After completing antiandrogen treatment in week 35, PSA level was 0.4 ng/mL."
        },
        {
            "procedure_name": "Radiation treatment",
            "date": "Weeks 8 to 16",
            "findings": "PSA level decreased to 4.6 ng/mL after radiation.",
            "changes_over_time": "Before radiation, PSA was 77 ng/mL; after radiation, it further decreased to 0.4 ng/mL."
        }
    ]
}